Skip to content
2000
image of Polymeric Nanoparticles: Innovative and Promising Tools for Enhanced Cancer Drug Delivery Systems
file format pdf download PDF

Abstract

Cancers characterized by uncontrolled cell proliferation and metastasis remain a major public health challenge worldwide. In Saudi Arabia, the increasing incidence necessitates comprehensive strategies for prevention, early detection, and effective treatment. Drug resistance, often driven by genetic mutations leading to multidrug resistance, remains a major clinical obstacle. The innovative delivery systems such as liposomes, polymeric nanoparticles, and exosomes are required to improve therapeutic efficacy. In this review, data from reputable databases and scientific sources such as Web of Science, PubMed, EMBASE, ScienceDirect, Scopus, and others, are critically compiled and analyzed. Strict inclusion criteria for peer-reviewed studies on polymeric nanoparticles in cancer therapy are applied, covering , , and clinical applications, while non-English-language, incomplete, or methodologically weak studies are excluded. Biodegradable polymeric nanoparticles such as PLGA, chitosan, and PCL have been shown to improve anticancer drug delivery by enabling precise targeting, reducing systemic toxicity, and overcoming multidrug resistance, with consistent therapeutic benefits observed in all studies. Despite these advances, challenges such as biocompatibility, toxicity, controlled release, tumor heterogeneity, long-term safety, and regulatory hurdles remain unresolved. Overall, nanoparticles represent a promising approach to cancer therapy as they improve drug delivery and minimize side effects, but sustained research and interdisciplinary collaboration are essential to fully exploit their potential in oncology.

© 2026 The Author(s).Published by Bentham Science Publisher.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128411216251118072842
2026-02-26
2026-03-03

  • From This Site

    /content/journals/cpd/10.2174/0113816128411216251118072842
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cpd/10.2174/0113816128411216251118072842/BMS-CPD-2025-533.html?itemId=/content/journals/cpd/10.2174/0113816128411216251118072842&mimeType=html&fmt=ahah

References

  1. Saeed Alqahtani W. Abdulrahman Almufareh N. Mostafa Domiaty D. Epidemiology of cancer in Saudi Arabia thru 2010-2019: A systematic review with constrained meta-analysis Running title: epidemiology of cancer in Saudi Arabia thru 2010-2019. AIMS Public Health 2020 7 3 679 696 10.3934/publichealth.202005332968686
    [Google Scholar]
  2. Moni S.S. Moshi J.M. Matou-Nasri S. Advances in materials science for precision melanoma therapy: Nanotechnology-enhanced drug delivery systems. Pharmaceutics 2025 17 3 296 10.3390/pharmaceutics1703029640142960
    [Google Scholar]
  3. Cancer, Fact sheets 2018 Available from: https://www.who.int/news-room/fact-sheets
  4. Althubiti M.A. Eldein M.M.N. Trends in the incidence and mortality of cancer in Saudi Arabia. Saudi Med. J. 2018 39 12 1259 1262 10.15537/smj.2018.12.2334830520511
    [Google Scholar]
  5. Mansoori B. Mohammadi A. Davudian S. Shirjang S. Baradaran B. The different mechanisms of cancer drug resistance: A brief review. Adv. Pharm. Bull. 2017 7 3 339 348 10.15171/apb.2017.041
    [Google Scholar]
  6. Li X. Li M. Huang M. The multi-molecular mechanisms of tumor-targeted drug resistance in precision medicine. Biomed. Pharmacother. 2022 150 113064 113064 10.1016/j.biopha.2022.113064
    [Google Scholar]
  7. Mitchell M.J. Billingsley M.M. Haley R.M. Wechsler M.E. Peppas N.A. Langer R. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 2021 20 2 101 124 10.1038/s41573‑020‑0090‑8
    [Google Scholar]
  8. Cree I.A. Charlton P. Molecular chess? Hallmarks of anti-cancer drug resistance. BMC Cancer 2017 17 1 10 10.1186/s12885‑016‑2999‑1
    [Google Scholar]
  9. Mazayen Z.M. Ghoneim A.M. Elbatanony R.S. Basalious E.B. Bendas E.R. Pharmaceutical nanotechnology: from the bench to the market Futur. J. Pharm. Sci. 2022 8 1 12 10.1186/s43094‑022‑00400‑0
    [Google Scholar]
  10. Patra J.K. Das G. Fraceto L.F. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnology 2018 16 1 71 10.1186/s12951‑018‑0392‑8
    [Google Scholar]
  11. Yilmaz M. Karanastasis A.A. Chatziathanasiadou M.V. Inclusion of quercetin in gold nanoparticles decorated with supramolecular hosts amplifies its tumor targeting properties. ACS Appl. Bio Mater. 2019 2 7 2715 2725 10.1021/acsabm.8b0074835030807
    [Google Scholar]
  12. Kuskov A.N. Kukovyakina E.V. Krasnoselskaya E.N. Nanotechnology-based drug delivery systems. Pharmaceutics 2025 17 7 817 Available from 10.3390/pharmaceutics17070817
    [Google Scholar]
  13. Gavas S. Quazi S. Karpiński T.M. Nanoparticles for cancer therapy: Current progress and challenges. Nanoscale Res. Lett. 2021 16 1 173 10.1186/s11671‑021‑03628‑6
    [Google Scholar]
  14. Yao Y. Zhou Y. Liu L. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front. Mol. Biosci. 2020 7 193 10.3389/fmolb.2020.00193
    [Google Scholar]
  15. Bhardwaj H Jangde RK Current updated review on preparation of polymeric nanoparticles for drug delivery and biomedical applications Next Nanotechnol 2023 2 100013 10.1016/j.nxnano.2023.100013
    [Google Scholar]
  16. Sun R Chen Y Pei Y Wang W Zhu Z Zheng Z Yang L Sun L The drug release of PLGA-based nanoparticles and their application in treatment of gastrointestinal cancers Heliyon 2024 10 18 e38165 10.1016/j.heliyon.2024.e38165
    [Google Scholar]
  17. Sun L Liu H Ye Y Lei Y Islam R Tan S Tong R Miao YB Cai L Smart nanoparticles for cancer therapy Signal Transduction and Targeted Therapy 2023 8 1 418 Available from: https://www.sciencedirect.com/science/chapter/edited-volume/abs/pii/B9780323527279000078?via%3Dihub
    [Google Scholar]
  18. Verma G Rajagopalan MD Valluru R Sridhar KA Nanoparticles: A novel approach to target tumors Grumezescu AM Nano- and microscale drug delivery systems: design and fabrication Amsterdam Elsevier 2017 113 134 Available from: https://www.sciencedirect.com/science/chapter/edited-volume/abs/pii/B9780323527279000078?via%3Dihub
    [Google Scholar]
  19. Thang N.H. Chien T.B. Cuong D.X. Polymer-Based Hydrogels Applied in Drug Delivery: An Overview. Gels 2023 9 7 523 10.3390/gels907052337504402
    [Google Scholar]
  20. Kumar A. Shahvej S.K. Yadav P. Clinical Applications of Targeted Nanomaterials. Pharmaceutics 2025 17 3 379 10.3390/pharmaceutics1703037940143042
    [Google Scholar]
  21. Puttasiddaiah R. Basavegowda N. Lakshmanagowda N.K. Emerging Nanoparticle-Based Diagnostics and Therapeutics for Cancer: Innovations and Challenges. Pharmaceutics 2025 17 1 70 10.3390/pharmaceutics1701007039861718
    [Google Scholar]
  22. Mahmoud A.M. Deambrogi C. Advancements in Nanotechnology for Targeted and Controlled Drug Delivery in Hematologic Malignancies: Shaping the Future of Targeted Therapeutics. Applied Biosciences 2025 4 1 16 10.3390/applbiosci4010016
    [Google Scholar]
  23. Rehan F. Zhang M. Fang J. Greish K. Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives. Molecules 2024 29 9 2073 10.3390/molecules2909207338731563
    [Google Scholar]
  24. Rashidi N. Davidson M. Apostolopoulos V. Nurgali K. Nanoparticles in cancer diagnosis and treatment: Progress, challenges, and opportunities. J. Drug Deliv. Sci. Technol. 2024 95 105599 10.1016/j.jddst.2024.105599
    [Google Scholar]
  25. Tiwari H. Rai N. Singh S. Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics. Bioengineering (Basel) 2023 10 7 760 10.3390/bioengineering1007076037508788
    [Google Scholar]
  26. Abdullah K.M. Sharma G. Singh A.P. Siddiqui J.A. Nanomedicine in Cancer Therapeutics: Current Perspectives from Bench to Bedside. Mol. Cancer 2025 24 1 169 10.1186/s12943‑025‑02368‑w40490771
    [Google Scholar]
  27. Javid-Naderi M.J. Abbasi Z. Fathi-karkan S. Advancements in nanocarrier-mediated sunitinib delivery: Addressing obstacles and revealing its therapeutic promise in oncological treatment. J. Drug Deliv. Sci. Technol. 2024 100 106107 106107 10.1016/j.jddst.2024.106107
    [Google Scholar]
  28. Wang B. Hu S. Teng Y. Current advance of nanotechnology in diagnosis and treatment for malignant tumors. Signal Transduct. Target. Ther. 2024 9 1 200 10.1038/s41392‑024‑01889‑y39128942
    [Google Scholar]
  29. Venturini J. Chakraborty A. Baysal M.A. Tsimberidou A.M. Developments in nanotechnology approaches for the treatment of solid tumors. Exp. Hematol. Oncol. 2025 14 1 76 10.1186/s40164‑025‑00656‑140390104
    [Google Scholar]
  30. Tamilarasi G.P. Sabarees G. Manikandan K. Gouthaman S. Alagarsamy V. Solomon V.R. Advances in electrospun chitosan nanofiber biomaterials for biomedical applications. Mater. Adv. 2023 4 15 3114 3139 10.1039/D3MA00010A
    [Google Scholar]
  31. Niculescu A.G. Grumezescu A.M. Applications of chitosan-alginate-based nanoparticles-an up-to-date review. Nanomaterials (Basel) 2022 12 2 186 10.3390/nano12020186
    [Google Scholar]
  32. Lakkakula J. Roy A. Krishnamoorthy K. Alginate-based nano systems for therapeutic applications. J. Nanomater. 2022 ••• 1 11
    [Google Scholar]
  33. González Z. Ferrandez-Montero A. Domínguez-Robles J. Recent Advances in Polymers as Matrices for Drug Delivery Applications. Pharmaceuticals (Basel) 2023 16 12 1674 10.3390/ph1612167438139801
    [Google Scholar]
  34. Safari J.B. Bapolisi A.M. Krause R.W.M. Development of pH-Sensitive Chitosan-g-poly(acrylamide-co-acrylic acid) Hydrogel for Controlled Drug Delivery of Tenofovir Disoproxil Fumarate. Polymers (Basel) 2021 13 20 3571 10.3390/polym1320357134685332
    [Google Scholar]
  35. Sanità G. Carrese B. Lamberti A. Nanoparticle surface functionalization: How to improve biocompatibility and cellular internalization. Front. Mol. Biosci. 2020 7 587012 10.3389/fmolb.2020.587012
    [Google Scholar]
  36. Kladko D.V. Falchevskaya A.S. Serov N.S. Prilepskii A.Y. Nanomaterial Shape Influence on Cell Behavior. Int. J. Mol. Sci. 2021 22 10 5266 10.3390/ijms22105266
    [Google Scholar]
  37. Nayan M.U. Panja S. Sultana A. Polymer Delivery Systems for Long-Acting Antiretroviral Drugs. Pharmaceutics 2024 16 2 183 10.3390/pharmaceutics1602018338399244
    [Google Scholar]
  38. Subhan M.A. Parveen F. Filipczak N. Yalamarty S.S.K. Torchilin V.P. Approaches to improve EPR-based drug delivery for cancer therapy and diagnosis. J. Pers. Med. 2023 13 3 389 Available from: https://www.mdpi.com/2075-4426/13/3/389
    [Google Scholar]
  39. Rafiei P. Haddadi A. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery. Mater. Sci. Eng. C 2019 104 109950 109950 10.1016/j.msec.2019.109950
    [Google Scholar]
  40. Hafezi Ghahestani Z. Alebooye Langroodi F. Mokhtarzadeh A. Ramezani M. Hashemi M. Evaluation of anti-cancer activity of PLGA nanoparticles containing crocetin. Artif. Cells Nanomed. Biotechnol. 2017 45 5 955 960 10.1080/21691401.2016.1198359
    [Google Scholar]
  41. Wu X. Zhang X. Xiao H. Xiao M. Nan K. Yan J. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. BMC Cancer 2020 20 1 354 Available from: https://link.springer.com/article/10.1186/s12885-020-06803-7
    [Google Scholar]
  42. Hu C. Nong S. Ke Q. Simultaneous co-delivery of Ginsenoside Rg3 and imiquimod from PLGA nanoparticles for effective breast cancer immunotherapy. iScience 2025 28 5 112274 10.1016/j.isci.2025.112274
    [Google Scholar]
  43. Jose S. Cinu T.A. Sebastian R. Transferrin-Conjugated Docetaxel-PLGA Nanoparticles for Tumor Targeting: Influence on MCF-7 Cell Cycle. Polymers (Basel) 2019 11 11 1905 10.3390/polym1111190531752417
    [Google Scholar]
  44. Takke A. Shende P. Magnetic-core-based silibinin nanopolymeric carriers for the treatment of renal cell cancer. Life Sci. 2021 275 119377 119377 10.1016/j.lfs.2021.11937733757771
    [Google Scholar]
  45. Cerioli N. Bououdina W. Mereu A. Reprogramming the melanoma and immunosuppressive myeloid cells with esomeprazole-loaded PLGA nanoparticles. iScience 2025 28 1 111559 10.1016/j.isci.2024.11155939839438
    [Google Scholar]
  46. Chen H. Wang Y. Zhou P. Chitosan surface-modified PLGA nanoparticles: Preparation, characterization, and evaluation of their in vitro drug-release behaviors and cytotoxicities. Curr. Nanosci. 2014 10 2 255 262 10.2174/15734137113096660113
    [Google Scholar]
  47. Sultan M.H. Moni S.S. Madkhali O.A. Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer. Sci. Rep. 2022 12 1 468 10.1038/s41598‑021‑04427‑w
    [Google Scholar]
  48. Maqsoodi R. Saberpour M. Bakhshi B. Fallah F. Effect of chitosan nanoparticles conjugated with the cell free supernatant of Bifidobacterium bifidum on the expression of genes related to colorectal cancer in colon adenocarcinoma (Caco-2) cell line. BMC Gastroenterol. 2025 25 1 394 10.1186/s12876‑025‑03923‑x40399800
    [Google Scholar]
  49. Sultan M.H. Moni S.S. Alqahtani S.S. Design, physicochemical characterisation, and in vitro cytotoxicity of cisplatin-loaded PEGylated chitosan injectable nano / sub-micron crystals. Saudi Pharm. J. 2023 31 6 861 873 10.1016/j.jsps.2023.04.005
    [Google Scholar]
  50. Li X. Li R. Qian X. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Eur. J. Pharm. Biopharm. 2008 70 3 726 734 10.1016/j.ejpb.2008.06.016
    [Google Scholar]
  51. Pan Q. Tian J. Zhu H. Tumor-targeting polycaprolactone nanoparticles with codelivery of paclitaxel and IR780 for combinational therapy of drug-resistant ovarian cancer. ACS Biomater. Sci. Eng. 2020 6 4 2175 2185 10.1021/acsbiomaterials.0c0016333455308
    [Google Scholar]
  52. Kolluru L.P. Chandran T. Shastri P.N. Rizvi S.A.A. D’Souza M.J. Development and evaluation of polycaprolactone based docetaxel nanoparticle formulation for targeted breast cancer therapy. J. Nanopart. Res. 2020 22 12 372 10.1007/s11051‑020‑05096‑y
    [Google Scholar]
  53. He Y. de Araújo Júnior R.F. Cavalcante R.S. Effective breast cancer therapy based on palmitic acid-loaded PLGA nanoparticles. Biomaterials Advances 2023 145 213270 213270 10.1016/j.bioadv.2022.213270
    [Google Scholar]
  54. Wang X. Cheng R. Zhong Z. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel. Acta Biomater. 2021 125 280 289 10.1016/j.actbio.2021.02.044
    [Google Scholar]
  55. da Luz CM Boyles MSP Falagan-Lotsch P Pereira MR Tutumi HR de Oliveira Santos E Poly-L-lysine-coated albumin nanoparticles: stability, cytotoxicity, and uptake Journal of Nanobiotechnology 2017 15 1 6 Available from: https://link.springer.com/article/10.1186/s12951-016-0238-1
    [Google Scholar]
  56. Dinarvand R. Sepehri, Manouchehri, Rouhani H, Atyabi F. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int. J. Nanomedicine 2011 6 877 895 10.2147/IJN.S18905
    [Google Scholar]
  57. Sakhi M. Khan A. Iqbal Z. Design and characterization of paclitaxel-loaded polymeric nanoparticles decorated with trastuzumab for the effective treatment of breast cancer. Front. Pharmacol. 2022 13 855294 10.3389/fphar.2022.855294
    [Google Scholar]
  58. Zhang D. Liu L. Wang J. Drug-loaded PEG-PLGA nanoparticles for cancer treatment. Front. Pharmacol. 2022 13 990505 10.3389/fphar.2022.990505
    [Google Scholar]
  59. Lee S. Miyajima T. Sugawara-Narutaki A. Kato K. Nagata F. Development of paclitaxel-loaded poly(lactic acid)/hydroxyapatite core-shell nanoparticles as a stimuli-responsive drug delivery system. R. Soc. Open Sci. 2021 8 3 202030 10.1098/rsos.202030
    [Google Scholar]
  60. Abriata JP Turatti RC Luiz MT Raspantini GL Tofani LB do Amaral RLF Development, characterization and biological-in vitro evaluation of folate-conjugated albumin nanoparticles for docetaxel cancer-based therapies Materials Science and Engineering C: Materials for Biological Applications 2019 97 623 631 Available from: http://dx.doi.org/10.4172/2157-7439.1000164
    [Google Scholar]
  61. Ma P. Mumper R.J. Paclitaxel nano-delivery systems: A comprehensive review. J. Nanomed. Nanotechnol. 2013 4 2 1000164 10.4172/2157‑7439.1000164
    [Google Scholar]
  62. Kousar K. Naseer F. Abduh M.S. Kakar S. Gul R. Anjum S. Green synthesis of hyaluronic acid coated, thiolated chitosan nanoparticles for CD44 targeted delivery and sustained release of Cisplatin in cervical carcinoma. Front. Pharmacol. 2023 13 1073004
    [Google Scholar]
  63. Anjum S. Naseer F. Ahmad T. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer. Sci. Rep. 2024 14 1 11431 10.1038/s41598‑024‑55900‑138763930
    [Google Scholar]
  64. Dongsar T.T. Dongsar T.S. Gupta N. Almalki W.H. Sahebkar A. Kesharwani P. Emerging potential of 5-Fluorouracil-loaded chitosan nanoparticles in cancer therapy. J. Drug Deliv. Sci. Technol. 2023 82 104371 104371 10.1016/j.jddst.2023.104371
    [Google Scholar]
  65. Bevacqua E. Curcio M. Saletta F. Vittorio O. Cirillo G. Tucci P. Dextran-curcumin nanosystems inhibit cell growth and migration regulating the epithelial to mesenchymal transition in prostate cancer cells. Int. J. Mol. Sci. 2021 22 13 7013 https://www.mdpi.com/1422-0067/22/13/7013
    [Google Scholar]
  66. Rudnik L.A.C. Farago P.V. Manfron Budel J. Lyra A. Barboza] FM, Klein T. Co-loaded curcumin and methotrexate nanocapsules enhance cytotoxicity against non-small-cell lung cancer cells. Molecules 2020 25 8 1913 10.3390/molecules25081913
    [Google Scholar]
  67. Liu S Qin S He M Zhou D Qin Q Wang H Current applications of poly (lactic acid) composites in tissue engineering and drug delivery. Compos Part B Eng 2020 199 108238 Available from: https://www.sciencedirect.com/science/article/abs/pii/S1359836820332881?via%3Dihub
    [Google Scholar]
  68. Kumari A. Mal A. Kaushik R.Y. Bandyopadhyaya R. PLGA-based nanoparticles for enhanced diagnosis and cancer therapy. Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery. Raj K. Cambridge, MA Academic Press 2023 179 210
    [Google Scholar]
  69. Silva L.Q.C. Raspantini G.L. Abriata J.P. PLGA/TPGS nanoparticles for docetaxel delivery: The pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells. J. Pharm. Sci. 2025 114 6 103766 10.1016/j.xphs.2025.103766
    [Google Scholar]
  70. Rezvantalab S. Drude N.I. Moraveji M.K. PLGA-based nanoparticles in cancer treatment. Front. Pharmacol. 2018 9 1260 10.3389/fphar.2018.0126030450050
    [Google Scholar]
  71. Senapati S. Mahanta A.K. Kumar S. Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct. Target. Ther. 2018 3 1 7 10.1038/s41392‑017‑0004‑3
    [Google Scholar]
  72. Rocha C.V. Gonçalves V. da Silva M.C. Bañobre-López M. Gallo J. PLGA-based composites for various biomedical applications. Int. J. Mol. Sci. 2022 23 4 2034 https://www.mdpi.com/1422-0067/23/4/2034
    [Google Scholar]
  73. Thomas O.S. Weber W. Overcoming physiological barriers to nanoparticle delivery-are we there yet? Front. Bioeng. Biotechnol. 2019 7 415 10.3389/fbioe.2019.00415
    [Google Scholar]
  74. Braden ARC Vishwanatha JK Kafka E Formulation of active agent-loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics US patent application US20080253961A1 2008 Available from: https://patentimages.storage.googleapis.com/4c/c0/15/9702d05e650e58/US20080253961A1.pdf
    [Google Scholar]
  75. Braden ARC Vishwanatha JK Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nanotherapeutics US Patent US9023395B2 2015Available from: https://patentimages.storage.googleapis.com/ec/cd/94/9f221506a1b966/US9023395.pdf
    [Google Scholar]
  76. Xu Peisheng He Huacheng Preparations of poly(lactic-co-glycolic acid)/polydopamine core/shell hybrid nanoparticle for photothermal applications US Patent US7210627B2 2016 Available from: https://patentimages.storage.googleapis.com/dd/48/c2/84ecb8af88f633/US10835605.pdf
    [Google Scholar]
  77. Blanco E Nested particles and the use thereof for coordinated delivery of active agents US Patent US10076509B2 2016 Available from: https://patentimages.storage.googleapis.com/34/77/d0/e2bb9f4edd092d/US10076509.pdf
    [Google Scholar]
  78. Zhanxia Z Lijun J Preparation method and application of biodegradable targeting molecule modified intelligent PLGA-SS-PEG nano-drug carrier China Patent CN112057620B 2019 Available from: https://patentimages.storage.googleapis.com/4a/db/18/e17d9db4b46a45/CN112057620B.pdf
    [Google Scholar]
  79. Nan Z Xiang L Weiyi S Astragalus polysaccharide composite nanoparticles and preparation method and application thereof China Patent CN118649148B 2024 Available from: https://patentimages.storage.googleapis.com/84/24/4f/4dc2ed15229ca9/CN118649148B.pdf
    [Google Scholar]
  80. Mikušová V Mikuš P Advances in chitosan-based nanoparticles for drug delivery Int J Mol Sci. 2021 22 17 9652 Available from: https://www.mdpi.com/1422-0067/22/17/9652
    [Google Scholar]
  81. Shiridokht F. Dadashi H. Vandghanooni S. Eskandani M. Farajollahi A. Metformin-loaded chitosan nanoparticles augment silver nanoparticle-induced radiosensitization in breast cancer cells during radiation therapy. Colloids Surf. B Biointerfaces 2025 245 114220 114220 10.1016/j.colsurfb.2024.11422039270400
    [Google Scholar]
  82. Bashir S.M. Ahmed Rather G. Patrício A. Chitosan nanoparticles: A versatile platform for biomedical applications. Materials (Basel) 2022 15 19 6521 10.3390/ma15196521
    [Google Scholar]
  83. Virmani T. Kumar G. Sharma A. Amelioration of cancer employing chitosan, its derivatives, and chitosan-based nanoparticles: recent updates. Polymers (Basel) 2023 15 13 2928 10.3390/polym1513292837447573
    [Google Scholar]
  84. Ding J. Guo Y. Ding, J.; Guo, Y. Recent advances in chitosan and its derivatives in cancer treatment. Front. Pharmacol. 2022 13 888740 10.3389/fphar.2022.88874035694245
    [Google Scholar]
  85. Krzyszczyk P Acevedo A Davidoff EJ The growing role of precision and personalized medicine for cancer treatment. Technology (Singap) 2018 6 03n04 79 100 10.1142/S2339547818300020
    [Google Scholar]
  86. Herdiana Y. Wathoni N. Shamsuddin S. Joni I.M. Muchtaridi M. Chitosan-Based Nanoparticles of Targeted Drug Delivery System in Breast Cancer Treatment. Polymers (Basel) 2021 13 11 1717 10.3390/polym13111717
    [Google Scholar]
  87. Masarudin M.J. Cutts S.M. Evison B.J. Phillips D.R. Pigram P.J. Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate drug delivery vehicles. Nanotechnol. Sci. Appl. 2015 8 67 80 Available from: https://www.dovepress.com/factors-determining-the-stability-size-distribution-and-cellular-accum-peer-reviewed-fulltext-article-NSA
    [Google Scholar]
  88. Jae-un N. Teuk-rae J. Su-young C. Mi-kyung J. Chang-yong C. Hydrophilic chitosan oligosaccharide nanoparticles containing an anticancer agent and hydrophobic bile acids. KR patent KR100762954B1. Available from 2006 [https://patents.google.com/patent/KR100762954B1
    [Google Scholar]
  89. Koyakutty M Malarvizhi G Nair S Nanoparticle formulations for delivering multiple therapeutic agents US Patent US10143700B2 2018 Available from: https://patentimages.storage.googleapis.com/e9/20/77/2c9e98a2e8173e/US10143700.pdf
    [Google Scholar]
  90. Reed J Krueger CG Madrigal-Carballo S Tannin-chitosan composites US Patent US10104888B2 2018 Available from: https://patentimages.storage.googleapis.com/37/0f/55/dcef4bc525823c/US10104888.pdf
    [Google Scholar]
  91. Ouyang X Liang J Ling J Lu Y Yang L Nanoparticle of adriamycin-coupled chitosan oligosaccharide China Patent CN113712939B 2022 Available from: https://patents.google.com/patent/CN113712939B/en
    [Google Scholar]
  92. Peyman GA Cancer treatment and imaging methods using thermotherapy and drug delivery US Patent Application US20210220480A1 2021 Available from: https://patentimages.storage.googleapis.com/fc/d8/73/edd5a9f7db31e5/US20210220480A1.pdf
    [Google Scholar]
  93. Allan J Belz S Hoeveler A Hugas M Okuda H Patlewicz G Regulatory toxicology and pharmacology: Regulatory landscape of nanotechnology and nanoplastics from a global perspective Regul Toxicol and Pharmacol. 2021 122 104885 Available from: https://www.sciencedirect.com/science/article/pii/S0273230021000258?via%3Dihub
    [Google Scholar]
  94. Nair NR Sekhar VC Nampoothiri KM Pandey A Biodegradation of biopolymers Pandey A Negi S Soccol CR Larroche C Current developments in biotechnology and bioengineering: production, isolation and purification of industrial products Amsterdam Elsevier 2017 739 755 Available from: https://www.sciencedirect.com/science/chapter/edited-volume/abs/pii/B9780444636621000324?via%3Dihub
    [Google Scholar]
  95. Ilyas R. Zuhri M. Norrrahim M. Natural fiber-reinforced polycaprolactone green and hybrid biocomposites for various advanced applications. Polymers (Basel) 2022 14 1 182 10.3390/polym14010182
    [Google Scholar]
  96. Socci M.C. Rodríguez G. Oliva E. Polymeric Materials, Advances and Applications in Tissue Engineering: A Review. Bioengineering (Basel) 2023 10 2 218 10.3390/bioengineering1002021836829712
    [Google Scholar]
  97. Bhadran A. Shah T. Babanyinah G.K. Recent Advances in Polycaprolactones for Anticancer Drug Delivery. Pharmaceutics 2023 15 7 1977 10.3390/pharmaceutics15071977
    [Google Scholar]
  98. Deng S. Gigliobianco M.R. Censi R. Di Martino P. Polymeric Nanocapsules as Nanotechnological Alternative for Drug Delivery System: Current Status, Challenges and Opportunities. Nanomaterials (Basel) 2020 10 5 847 10.3390/nano1005084732354008
    [Google Scholar]
  99. Shastri V. Non-degradable biocompatible polymers in medicine: Past, present, and future. Curr Pharm Biotechno 2003 4 5 331 7 10.2174/1389201033489694
    [Google Scholar]
  100. Sohail M.F. Hussain S.Z. Saeed H. Polymeric nanocapsules embedded with ultra-small silver nanoclusters for synergistic pharmacology and improved oral delivery of Docetaxel. Sci. Rep. 2018 8 1 13304 10.1038/s41598‑018‑30749‑330190588
    [Google Scholar]
  101. Ali I. Alsehli M. Scotti L. Progress in Polymeric Nano-Medicines for Theranostic Cancer Treatment. Polymers (Basel) 2020 12 3 598 10.3390/polym1203059832155695
    [Google Scholar]
  102. Thoniyot P. Tan M.J. Karim A.A. Young D.J. Loh X.J. Nanoparticle-hydrogel composites: Concept, design, and applications of these promising, multi-functional materials. Adv. Sci. (Weinh.) 2015 2 1-2 1400010 10.1002/advs.201400010
    [Google Scholar]
  103. Nunes D. Andrade S. Ramalho M.J. Loureiro J.A. Pereira M.C. Polymeric Nanoparticles-Loaded Hydrogels for Biomedical Applications: A Systematic Review on In Vivo Findings. Polymers (Basel) 2022 14 5 1010 10.3390/polym1405101035267833
    [Google Scholar]
  104. Sivakumar S.M. Bremnavas I.M. Evaluation of potential drug candidates for the treatment of COVID-19: A molecular docking study. J. Biomol. Struct. Dyn. 2020 38 11 3352 3363
    [Google Scholar]
  105. Hossen S. Hossain M.K. Basher M.K. Mia M.N.H. Rahman M.T. Uddin M.J. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review. J. Adv. Res. 2019 15 1 18 10.1016/j.jare.2018.06.00530581608
    [Google Scholar]
  106. Yu W. Liu R. Zhou Y. Gao H. Size-tunable strategies for a tumor targeted drug delivery system. ACS Cent. Sci. 2020 6 2 100 116 10.1021/acscentsci.9b01139
    [Google Scholar]
  107. Zein R. Sharrouf W. Selting K. Physical properties of nanoparticles that result in improved cancer targeting. J. Oncol. 2020 2020 1 16 10.1155/2020/5194780
    [Google Scholar]
  108. Ribatti D. Pezzella F. Overview on the different patterns of tumor vascularization. Cells 2021 10 3 639 10.3390/cells10030639
    [Google Scholar]
  109. Martin J.D. Seano G. Jain R.K. Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges. Annu. Rev. Physiol. 2019 81 1 505 534 10.1146/annurev‑physiol‑020518‑11470030742782
    [Google Scholar]
  110. Behzadi S. Serpooshan V. Tao W. Cellular uptake of nanoparticles: Journey inside the cell. Chem. Soc. Rev. 2017 46 14 4218 4244 10.1039/C6CS00636A
    [Google Scholar]
  111. Awad N.S. Salkho N.M. Abuwatfa W.H. Paul V. AlSawaftah N.M. Husseini G.A. Tumor vasculature vs tumor cell targeting: Understanding the latest trends in using functional nanoparticles for cancer treatment. OpenNano 2023 11 100136 100136 10.1016/j.onano.2023.100136
    [Google Scholar]
  112. Raj S. Khurana S. Choudhari R. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy. Semin. Cancer Biol. 2021 69 166 177 10.1016/j.semcancer.2019.11.002
    [Google Scholar]
  113. Deivayanai V.C. Thamarai P. Karishma S. Advances in nanoparticle-mediated cancer therapeutics: Current research and future perspectives. Cancer Pathog Ther 2024 3 4 293 308 10.1016/j.cpt.2024.11.00240697517
    [Google Scholar]
  114. Sykes E.A. Chen J. Zheng G. Chan W.C.W. Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. ACS Nano 2014 8 6 5696 5706 10.1021/nn500299p
    [Google Scholar]
  115. Bazak R. Houri M. Achy S.E. Hussein W. Refaat T. Passive targeting of nanoparticles to cancer: A comprehensive review of the literature. Mol. Clin. Oncol. 2014 2 6 904 908 10.3892/mco.2014.356
    [Google Scholar]
  116. Al-Thani A.N. Jan A.G. Abbas M. Geetha M. Sadasivuni K.K. Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review. Life Sci. 2024 352 122899 122899 10.1016/j.lfs.2024.122899
    [Google Scholar]
  117. Xu M. Han X. Xiong H. Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials. Molecules 2023 28 13 5145 10.3390/molecules2813514537446806
    [Google Scholar]
  118. Xuan L. Ju Z. Skonieczna M. Zhou P.K. Huang R. Nanoparticles-induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models. MedComm 2023 4 4 327 10.1002/mco2.327
    [Google Scholar]
  119. Chehelgerdi M. Chehelgerdi M. Allela O.Q.B. Pecho R.D. Martins N. Sharifi-Rad J. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol. Cancer 2023 22 1 169 [https://doi.org/10.1186/s12943-023-01865-0
    [Google Scholar]
  120. Skotland T. Iversen T.G. Llorente A. Sandvig K. Biodistribution, pharmacokinetics and excretion studies of intravenously injected nanoparticles and extracellular vesicles: Possibilities and challenges. Advanced Drug Deliv. Rev. 2022 186 114326
    [Google Scholar]
  121. Zhou L. Zou M. Xu Y. Lin P. Lei C. Xia X. Peptide-modified silver nanoparticles for targeted cancer therapy to overcome drug resistance. J. Nanobiotechnology 2022 20 1 252
    [Google Scholar]
/content/journals/cpd/10.2174/0113816128411216251118072842
Loading
Polymeric Nanoparticles: Innovative and Promising Tools for Enhanced Cancer Drug Delivery Systems
Bentham Science Publishers ; https://doi.org/10.2174/0113816128411216251118072842
/content/journals/cpd/10.2174/0113816128411216251118072842
/content/journals/cpd/10.2174/0113816128411216251118072842
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: drug resistance ; Cancer ; chemotherapy ; biodegradable polymers ; targeted drug delivery ; nanotechnology ; tumor heterogeneity ; polymeric nanoparticles

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test